Advanced company searchLink opens in new window

PANDEIA THERAPEUTICS LIMITED

Company number 11463856

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 Apr 2024 AD01 Registered office address changed from C/O the Cambridge Partnership Ltd, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH United Kingdom to The Cambridge Partnership the Dorothy Hodgkin Bldg Babraham Research Campus Babraham Cambridge CB22 3FH on 30 April 2024
29 Apr 2024 AP01 Appointment of Jennifer Rhodes as a director on 26 April 2024
29 Apr 2024 TM01 Termination of appointment of Austin Kim as a director on 26 April 2024
06 Dec 2023 AA01 Current accounting period extended from 31 August 2023 to 31 December 2023
04 Jul 2023 CS01 Confirmation statement made on 26 June 2023 with updates
28 Jun 2023 AD02 Register inspection address has been changed from 29a Rectory Lane Rectory Lane Lymm WA13 0AJ England to The Cambridge Partnership the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH
28 Jun 2023 PSC02 Notification of Acadia Pharmaceuticals Inc. as a person with significant control on 22 December 2022
04 Jan 2023 AP01 Appointment of Austin Kim as a director on 22 December 2022
04 Jan 2023 MA Memorandum and Articles of Association
04 Jan 2023 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Jan 2023 TM01 Termination of appointment of John Fraser Murray as a director on 22 December 2022
03 Jan 2023 TM01 Termination of appointment of David John Grainger as a director on 22 December 2022
03 Jan 2023 TM01 Termination of appointment of Francesco De Rubertis as a director on 22 December 2022
03 Jan 2023 PSC07 Cessation of Medicxi Ventures I Lp as a person with significant control on 22 December 2022
05 Oct 2022 AA Accounts for a small company made up to 31 August 2022
03 Aug 2022 AA01 Current accounting period shortened from 31 December 2022 to 31 August 2022
27 Jun 2022 CS01 Confirmation statement made on 26 June 2022 with updates
19 May 2022 RP04SH01 Second filing of a statement of capital following an allotment of shares on 8 September 2021
  • GBP 5,061.806
24 Mar 2022 AA Total exemption full accounts made up to 31 December 2021
07 Oct 2021 SH01 Statement of capital following an allotment of shares on 8 September 2021
  • GBP 5,061.806
  • ANNOTATION Clarification a second filed SH01 was registered on 19/05/22
30 Jul 2021 CS01 Confirmation statement made on 26 June 2021 with updates
16 Feb 2021 AA Total exemption full accounts made up to 31 December 2020
01 Dec 2020 SH01 Statement of capital following an allotment of shares on 30 November 2020
  • GBP 3,041.255
01 Dec 2020 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities
01 Dec 2020 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities